NR1H4 and metabolic dysfunction-associated steatohepatitis: Additionally, DG modulates bile acid metabolism via the hepatic FXR-SHP and intestinal FXR-FGF15 pathways, suggesting its protective role against NASH through altering the Clostridium populations and bile acid dynamics [85,86].